Meanwhile, TSP50 shRNA-stably transfected breast cancer cells revealed a lower CD44+/CD24− cell ratio and ALDH activity (Fig. 4K and L, Fig. S3L-N). This evidence concerns the gene PRSS50 and breast cancer.